BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20874724)

  • 1. GATA4 regulates ANF expression synergistically with Sp1 in a cardiac hypertrophy model.
    Hu X; Li T; Zhang C; Liu Y; Xu M; Wang W; Jia Z; Ma K; Zhang Y; Zhou C
    J Cell Mol Med; 2011 Sep; 15(9):1865-77. PubMed ID: 20874724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
    Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
    J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendropanax morbifera Prevents Cardiomyocyte Hypertrophy by Inhibiting the Sp1/GATA4 Pathway.
    Sun S; Li T; Jin L; Piao ZH; Liu B; Ryu Y; Choi SY; Kim GR; Jeong JE; Wi AJ; Lee SJ; Kee HJ; Jeong MH
    Am J Chin Med; 2018; 46(5):1021-1044. PubMed ID: 29986596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MITF interacts with the SWI/SNF subunit, BRG1, to promote GATA4 expression in cardiac hypertrophy.
    Mehta G; Kumarasamy S; Wu J; Walsh A; Liu L; Williams K; Joe B; de la Serna IL
    J Mol Cell Cardiol; 2015 Nov; 88():101-10. PubMed ID: 26388265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sp3 Transcription Factor Cooperates with the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein To Synergistically Activate Specific Viral and Cellular Gene Promoters.
    Chen LY; Chen LW; Peng KT; Hung CH; Chang PJ; Wang SS
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p65 subunit of NF-κB inhibits COL1A1 gene transcription in human dermal and scleroderma fibroblasts through its recruitment on promoter by protein interaction with transcriptional activators (c-Krox, Sp1, and Sp3).
    Beauchef G; Bigot N; Kypriotou M; Renard E; Porée B; Widom R; Dompmartin-Blanchere A; Oddos T; Maquart FX; Demoor M; Boumediene K; Galera P
    J Biol Chem; 2012 Jan; 287(5):3462-78. PubMed ID: 22139845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Catenin/TCF/LEF1 can directly regulate phenylephrine-induced cell hypertrophy and Anf transcription in cardiomyocytes.
    Zhang CG; Jia ZQ; Li BH; Zhang H; Liu YN; Chen P; Ma KT; Zhou CY
    Biochem Biophys Res Commun; 2009 Dec; 390(2):258-62. PubMed ID: 19799869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
    Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
    Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gata4 and Sp1 regulate expression of the erythropoietin receptor in cardiomyocytes.
    Salisch Sv; Klar M; Thurisch B; Bungert J; Dame C
    J Cell Mol Med; 2011 Sep; 15(9):1963-72. PubMed ID: 21029371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivo.
    Azakie A; Fineman JR; He Y
    Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H600-11. PubMed ID: 16617124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative roles for c-Jun N-terminal kinase, c-Jun, serum response factor, and Sp1 in calcium-regulated myocardial gene expression.
    McDonough PM; Hanford DS; Sprenkle AB; Mellon NR; Glembotski CC
    J Biol Chem; 1997 Sep; 272(38):24046-53. PubMed ID: 9295358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4.
    Xiang F; Sakata Y; Cui L; Youngblood JM; Nakagami H; Liao JK; Liao R; Chin MT
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1997-2006. PubMed ID: 16603706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
    Liu Y; Wang Z; Xiao W
    Mol Med Rep; 2016 Sep; 14(3):2860-6. PubMed ID: 27485101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes.
    Morisco C; Seta K; Hardt SE; Lee Y; Vatner SF; Sadoshima J
    J Biol Chem; 2001 Jul; 276(30):28586-97. PubMed ID: 11382772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
    Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
    J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-related receptor gamma induces cardiac hypertrophy by activating GATA4.
    Kwon DH; Eom GH; Kee HJ; Nam YS; Cho YK; Kim DK; Koo JY; Kim HS; Nam KI; Kim KK; Lee IK; Park SB; Choi HS; Kook H
    J Mol Cell Cardiol; 2013 Dec; 65():88-97. PubMed ID: 24083978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the rat connexin 43 proximal promoter in neonatal cardiomyocytes.
    Teunissen BE; Jansen AT; van Amersfoorth SC; O'Brien TX; Jongsma HJ; Bierhuizen MF
    Gene; 2003 Dec; 322():123-36. PubMed ID: 14644504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone signaling associates with p300/GATA4 transcriptional pathway during the hypertrophic response of cardiomyocytes.
    Yoshida Y; Morimoto T; Takaya T; Kawamura T; Sunagawa Y; Wada H; Fujita M; Shimatsu A; Kita T; Hasegawa K
    Circ J; 2010 Jan; 74(1):156-62. PubMed ID: 19966502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentisic acid attenuates pressure overload-induced cardiac hypertrophy and fibrosis in mice through inhibition of the ERK1/2 pathway.
    Sun S; Kee HJ; Jin L; Ryu Y; Choi SY; Kim GR; Jeong MH
    J Cell Mol Med; 2018 Dec; 22(12):5964-5977. PubMed ID: 30256522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial transcription factors are modulated during pathologic cardiac hypertrophy in vivo.
    Azakie A; Fineman JR; He Y
    J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1262-71. PubMed ID: 17140938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.